Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools

View
Repeats

This event has passed. Follow up on this event's outcomes through the related Headlines linked below to or skip to the event data.

Related Headlines

FDA's Growing Role Regulating Health 2.0, Health IT

The Food and Drug Administration likely will play an increasingly important role in regulating health information technology.

Drug Makers to Press for Guidance on Web Marketing

Eager to expand use of the Web to advertise their products, pharmaceutical giants, including Eli Lilly and Pfizer, are heading to Washington this week to call on the Food and Drug Administration to provide guidelines for marketing prescription drugs online.

Drug industry presses FDA to allow more online ads

As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.

Google Has A Plan For Safer, More Useful Online Drug Ads

When Google talks about online ads, everybody listens. So check out the Internet giant's idea for rejiggering online promotion of prescription drugs to pass muster with the Food and Drug Administration.

PhRMA Proposes FDA-Approved Logo for Marketing in Social Media

The Pharmaceutical Research and Manufacturers of America is advocating for a universal safety symbol -- either the Food and Drug Administration logo itself or an FDA-approved symbol -- to indicate that a Twitter or Facebook mention links to a page that contains the pharmaceutical company's FDA-mandated risk information.

Event Details

Date: Nov 12 2009 - 8:00am - Nov 13 2009 - 5:00pm

Public Hearing on Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools

Food and Drug Administration
National Transportation Safety Board Conference Center
429 L'Enfant Plaza, SW., Washington DC, 20594
November 12 and 13, 2009
8:00 a.m. to 5:00 p.m. each day
http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm184250.htm

The Food and Drug Administration (FDA) will hold a public hearing to provide an opportunity for broad public participation and comment on promotion of FDA-regulated medical products (including prescription drugs for humans and animals, prescription biologics, and medical devices) using the Internet and social media tools. FDA is seeking participation in the public hearing and written comments from all interested parties, including, but not limited to, consumers, patients, caregivers, health care professionals, patient groups, Internet vendors, advertising agencies, and the regulated industry. This meeting and written comments are intended to help guide FDA in making policy decisions on the promotion of human and animal prescription drugs and biologics and medical devices using the Internet and social media tools. FDA is seeking input on a number of specific questions but is interested in any other pertinent information participants in the hearing would like to share.